{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:32:39Z","timestamp":1791145959976,"version":"4.1.0"},"reference-count":35,"publisher":"EDP Sciences","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1051\/medsci\/2004205562","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T10:40:29Z","timestamp":1299321629000},"page":"562-568","source":"Crossref","is-referenced-by-count":28,"title":["Facteurs de risque g\u00e9n\u00e9tiques pour le cancer de la prostate"],"prefix":"10.1051","volume":"20","author":[{"given":"Olivier","family":"Cussenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Cancel-Tassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2004,5,15]]},"reference":[{"key":"R1","unstructured":"http:\/\/www-dep.iarc.fr, 2000."},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Labrie F, Candas B, Dupont A,et al.Screening decreases prostate cancer death : First analysis of the 1988 Quebec prospective randomized controlled trial.Prostate1999; 38 : 83\u201391.","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Cussenot O, Valeri A. Heterogeneity in genetic susceptibility to prostate cancer.Eur J Intern Med2001; 12 : 11\u20136.","DOI":"10.1016\/S0953-6205(00)00136-9"},{"key":"R4","unstructured":"Cussenot O, Fournier G. G\u00e9n\u00e9tique et urologie. Paris : les \u00c9ditions Vingt et un. Progr\u00e8s en Urologie 2000 : 417p."},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Morganti G, Gianferrari L, Cresseri A,et al.Recherches clinico-statistiques et g\u00e9n\u00e9tiques sur les n\u00e9oplasies de la prostate.Acta Genet Stat Med1956; 6 : 304\u20135.","DOI":"10.1159\/000150844"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Gr\u00f6nberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in twin population.J Urol1994; 152 : 1484\u20139.","DOI":"10.1016\/S0022-5347(17)32452-7"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Schaid DJ, McDonnell SK, Blute ML,et al.Evidence for autosomal dominant inheritance of prostate cancer.Am J Hum Genet1998; 62 : 1425\u201338.","DOI":"10.1086\/301862"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"Carter BS, Beaty TH, Steinberg GD,et al.Mendelian inheritance of familial prostate cancer.Proc Natl Acad SciUSA 1992; 89 : 3367\u201371.","DOI":"10.1073\/pnas.89.8.3367"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"Xu J and the International consortium for prostate cancer genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25 : results from 772 hereditary prostate cancer families from the International consortium for prostate cancer genetics.Am J Hum Genet2000; 66 : 945\u201357.","DOI":"10.1086\/302807"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Berthon P, Valeri A, Cohen-Akenine A,et al.Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43.Am J Hum Genet1998; 62 : 1416\u201324.","DOI":"10.1086\/301879"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Cancel-Tassin G, Latil A, Valeri A,et al.PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.Eur J Hum Genet2001; 9 : 135\u201342.","DOI":"10.1038\/sj.ejhg.5200592"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Karayi MK, Neal DE, Markham AF. Current status of linkage studies in hereditary prostate cancer.BJU Int2000; 86 : 659\u201369.","DOI":"10.1046\/j.1464-410x.2000.00837.x"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Valeri A, Azzouzi R, Drelon E,et al.Early-onset hereditary prostate cancer is not associated with specific clinical biological features.Prostate2000; 45 : 66\u201371.","DOI":"10.1002\/1097-0045(20000915)45:1<66::AID-PROS8>3.0.CO;2-W"},{"key":"R14","unstructured":"Goode EL, Stanford JL, Peters MA,et al.Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.Clin CancerRes 2001; 7 : 2739\u201349."},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Bratt O. Hereditary prostate cancer : Clinical aspects.J Urol2002; 168 : 906\u201313.","DOI":"10.1016\/S0022-5347(05)64541-7"},{"key":"R16","doi-asserted-by":"crossref","unstructured":"Valeri A, Fournier G, Morin V,et al.Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives.Int J Cancer2000; 86 : 883\u20137.","DOI":"10.1002\/(SICI)1097-0215(20000615)86:6<883::AID-IJC20>3.0.CO;2-F"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Edwards SM, Kote-Jarai Z, Meitz J,et al.Two percent of men with early-onset prostate cancer harbor germline mutations in theBRCA2gene.Am J Hum Genet2003; 72 : 1\u201312.","DOI":"10.1086\/345310"},{"key":"R18","unstructured":"Gayther SA, de Foy KA, Harrington P,et al.The frequency of germ-line mutations in the breast cancer predisposition genesBRCA1andBRCA2in familial prostate cancer. The cancer research campaign\/British prostate group united kingdom familial prostate cancer study collaborators.CancerRes 2000; 60 : 4513\u20138."},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Jonsson BA, Bergh A, Stattin P,et al.Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.Int J Cancer2002; 98 : 838\u201343.","DOI":"10.1002\/ijc.10258"},{"key":"R20","unstructured":"Ross RK, Pike MC, Coetzee GA,et al.Androgen metabolism and prostate cancer : Establishing a model of genetic susceptibility.Cancer Res1998; 58 : 4497\u2013504."},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Bosland MC. The role of steroid hormones in prostate carcinogenesis.J Natl Cancer Inst Monogr2000; 27 : 39\u201366.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244"},{"key":"R22","unstructured":"Irvine RA, Yu MC, Ross RK,et al.The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.Cancer Res1995; 55 : 1937\u201340."},{"key":"R23","doi-asserted-by":"crossref","unstructured":"Edwards A, Hammond HA, Jin L,et al.Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.Genomics1992; 12 : 241\u201353.","DOI":"10.1016\/0888-7543(92)90371-X"},{"key":"R24","doi-asserted-by":"crossref","unstructured":"Rebbeck TR, Jaffe JM, Walker AH,et al.Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.J Natl Cancer Inst1998; 90 : 1225\u20139.","DOI":"10.1093\/jnci\/90.16.1225"},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Lunn RM, Bell DA, Mohler JL,et al.Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).Carcinogenesis1999; 20 : 1727\u201331.","DOI":"10.1093\/carcin\/20.9.1727"},{"key":"R26","unstructured":"Chang BL, Zheng SL, Hawkins GA,et al.Joint effect ofHSD3B1andHSD3B2genes is associated with hereditary and sporadic prostate cancer susceptibility.Cancer Res2002; 62 : 1784\u20139"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Latil A, Azzouzi R, Cancel G,et al.Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways.Cancer2001; 92 : 1130\u20137.","DOI":"10.1002\/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Cancel-Tassin G, Latil A, Rousseau F,et al.Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.Eur Urol2003; 44 : 487\u201390.","DOI":"10.1016\/S0302-2838(03)00319-1"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Tang YM, Green BL, Chen GF,et al.Human CYP1B1 Leu432Val gene polymorphism : ethnic distribution in African-Americans, Caucasians and Chinese ; oestradiol hydroxylase activity ; and distribution in prostate cancer cases and controls.Pharmacogenetics2000; 10 : 761\u20136.","DOI":"10.1097\/00008571-200012000-00001"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Correa-Cerro L, Berthon P, Haussler J,et al.Vitamin D receptor polymorphisms as markers in prostate cancer.Human Genet1999; 105 : 281\u20137.","DOI":"10.1007\/s004390051102"},{"key":"R31","unstructured":"Reszka E, Wasowicz W. Genetic polymorphism of N-acetyltransferase and glutathione S-transferase related to neoplasm of genitourinary system.Neoplasma2002; 49 : 209\u201316."},{"key":"R32","doi-asserted-by":"crossref","unstructured":"Simard J, Dumont M, Soucy P,et al.Perspective : prostate cancer susceptibility genes.Endocrinology2002; 143 : 2029\u201340.","DOI":"10.1210\/endo.143.6.8890"},{"key":"R33","doi-asserted-by":"crossref","unstructured":"Nwosu V, Carpten J, Trent JM,et al.Heterogeneity of genetic alterations in prostate cancer : Evidence of the complex nature of the disease.Hum Mol Genet2001; 10 : 2313\u20138.","DOI":"10.1093\/hmg\/10.20.2313"},{"key":"R34","doi-asserted-by":"crossref","unstructured":"Valeri A, Cormier L, Moineau MP,et al.Targeted screening for prostate cancer in high risk families : Early onset is a significant risk factor for disease in first degree relatives.J Urol2002; 168 : 483\u20137.","DOI":"10.1016\/S0022-5347(05)64663-0"},{"key":"R35","doi-asserted-by":"crossref","unstructured":"Novelli G, Margiotti K, Sangiuolo F,et al.Pharmacogenetics of human androgens and prostatic diseases.Pharmacogenomics2001; 2 : 65\u201372.","DOI":"10.1517\/14622416.2.1.65"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004205562\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T21:35:59Z","timestamp":1560029759000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2004205562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":35,"journal-issue":{"issue":"5"},"alternative-id":["medsci2004205p562"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2004205562","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}